ES2182554T3 - Composiciones farmaceuticas que comprenden hiddroxilansoprazol y uso de las mismas. - Google Patents

Composiciones farmaceuticas que comprenden hiddroxilansoprazol y uso de las mismas.

Info

Publication number
ES2182554T3
ES2182554T3 ES99937321T ES99937321T ES2182554T3 ES 2182554 T3 ES2182554 T3 ES 2182554T3 ES 99937321 T ES99937321 T ES 99937321T ES 99937321 T ES99937321 T ES 99937321T ES 2182554 T3 ES2182554 T3 ES 2182554T3
Authority
ES
Spain
Prior art keywords
hydroxylansoprazole
hiddroxylansoprazol
same
pharmaceutical compositions
lansoprazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99937321T
Other languages
English (en)
Inventor
William E Yelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of ES2182554T3 publication Critical patent/ES2182554T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Composición farmacéutica que comprende un portador farmacéuticamente aceptable para la terapia oral y una cantidad terapéuticamente efectiva de hidroxilansoprazol o de una sal farmacéuticamente aceptable del mismo.
ES99937321T 1998-07-22 1999-07-19 Composiciones farmaceuticas que comprenden hiddroxilansoprazol y uso de las mismas. Expired - Lifetime ES2182554T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9376298P 1998-07-22 1998-07-22

Publications (1)

Publication Number Publication Date
ES2182554T3 true ES2182554T3 (es) 2003-03-01

Family

ID=22240576

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99937321T Expired - Lifetime ES2182554T3 (es) 1998-07-22 1999-07-19 Composiciones farmaceuticas que comprenden hiddroxilansoprazol y uso de las mismas.

Country Status (9)

Country Link
US (3) US6335351B1 (es)
EP (1) EP1098648B1 (es)
JP (1) JP2002521336A (es)
AT (1) ATE225175T1 (es)
AU (1) AU763642B2 (es)
CA (1) CA2337886C (es)
DE (1) DE69903315T2 (es)
ES (1) ES2182554T3 (es)
WO (1) WO2000004904A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100434904B1 (ko) * 2002-05-30 2004-06-11 주식회사 대웅 안정화된 란소프라졸을 함유하는 장용성 제제

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
AU763642B2 (en) 2003-07-31
CA2337886A1 (en) 2000-02-03
DE69903315T2 (de) 2003-06-18
EP1098648A1 (en) 2001-05-16
JP2002521336A (ja) 2002-07-16
US20040077688A1 (en) 2004-04-22
US7098224B2 (en) 2006-08-29
EP1098648B1 (en) 2002-10-02
ATE225175T1 (de) 2002-10-15
DE69903315D1 (de) 2002-11-07
WO2000004904A1 (en) 2000-02-03
US6335351B1 (en) 2002-01-01
AU5218299A (en) 2000-02-14
CA2337886C (en) 2008-04-08
US20020099079A1 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
ATE288893T1 (de) Polymorphe form von atorvastatin-calcium
NO20000265D0 (no) Kontrollert cytolyse av målceller, midler og sammensetninger som forårsaker cytolyse og forbindelser som kan anvendes for å fremstille midlene
DK0705100T3 (da) Terapeutiske substituerede guanidiner
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE310826T1 (de) Induktion von männlicher sterilität in pflanzen durch erhöhte expression von streptavidin
NO20016232D0 (no) Amorfe salpetersyre-estere og farmasöytiske preparater inneholdene disse
HUP0103203A2 (hu) Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények
BR9106367A (pt) Acidos e n-hidroxiureias anti-inflamatorias
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
NO984950L (no) Forbindelser med veksthormonfrigj°rende egenskaper
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
DE69902657D1 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
DE69231384D1 (de) Zusammensetzungen zur behandlung des chronischen erschöpfungs-syndroms
ES2182554T3 (es) Composiciones farmaceuticas que comprenden hiddroxilansoprazol y uso de las mismas.
DK0530639T3 (da) Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere
ATE301461T1 (de) Desmethylpantoprazol-zusammensetzungen und verfahren
NO913661D0 (no) Anordning og fremgangsmaate for dosering av vaskemiddelkompositter.
TR200103240T2 (tr) Endoparazit öldürücü bileşimler.
DE60108272D1 (de) Pharmazeutische zusammensetzung enthaltend (-)-secoisolariciresinol
DE60336417D1 (de) Flüssige zusammensetzungen mit 3,7-diazabicycloä3,3,1ü nonanen zur behandlung von anti-arrhythmischen ereignissen
DE60112117D1 (de) Warmgeformte feste arzneizusammensetzung zur gesteuerten wirkstoffabgabe von perindopril